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Introduction
Dobutamine is an effective pharmacologic stress agent
commonly used in cardiac stress testing, but has several
well documented adverse effects including serious
arrhythmias and myocardial infarction. The most com-
mon dobutamine protocol is to infuse an increasing
dose of 10 µg/kg followed by 20, 30, then 40 µg/kg until
target HR is achieved. Atropine may be added after the
40 µg/kg infusion if target heart rate is not achieved. An
alternative strategy for dobutamine infusion involves
earlier atropine administration, i.e. infusion of atropine
after the 10, 20, or 30 µg/kg doses of dobutamine. In
the echocardiography literature this strategy has been
shown to have a better safety profile while maintaining
the ability to achieve target heart rate. Dobutamine
stress CMR may benefit from adopting a similar
protocol.
Purpose
The objective of this study is to assess the safety and
efficacy of the addition of early atropine injection to
dobutamine for stress CMR.
Methods
This is a single center, retrospective study involving 168
patients undergoing early-atropine dobutamine stress
CMR for the evaluation of chest pain. All patients
underwent a hybrid stress CMR protocol with evalua-
tion of wall motion, perfusion, and late gadolinium
enhancement. Demographic and stress CMR data are
gathered from an electronic medical records system.
The stress CMR data that were collected included the
doses of dobutamine and atropine administered, the
time of atropine infusion, the heart rate and blood pres-
sure responses, and the incidence of adverse effects. All
data are entered into a Microsoft Excel spreadsheet,
where statistical analyses were performed.
Results
The mean age of the patients undergoing CMR was 70.8
± 7.6 years, with 91 females and 77 males. 156 patients
were Asian, 8 were Caucasian, and 3 were Hispanic. 128
patients had hypertension, 96 had hyperlipidemia, and
46 had diabetes. 53 patients had documented coronary
artery disease. Patients received an average of 8.5 ± 4.8
mg of dobutamine and 0.26 ± 0.19mg of atropine during
the examination. Of 168 patients, 158(94%) achieved tar-
get heart rate or85% of maximum predicted. In our
population, 14 patients were positive for ischemia. Of
168 examinations, 167 were considered of diagnostic
quality. Three patients were hypotensive during the
examination, while 1 was hypertensive 3 reported chest
pain, and 1 reported dizziness. Tables 1-3, figure 1.
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Table 1 Patient demographics
Age 70.8 ± 7.6 years
Gender 45.8% males
Hypertension 76.2%
Hypercholesterolemia 57.1%
Diabetes 26.2%
Coronary Artery disease 31.5%
Past Myocardial Infarction 9.5%
Past Percutaenous Coronary Intervention 10.7%
Past Coronary Artery Bypass Graft 11.9%
Congestive Heart Failure 4.2%
Woo et al. Journal of Cardiovascular Magnetic Resonance 2011, 13(Suppl 1):P127
http://jcmr-online.com/content/13/S1/P127
© 2011 Woo et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.Conclusions
The early-atropine, dobutamine stress CMR test can be
performed with an excellent safety profile and a lower
dose of stress agent compared with the standard late-
atropine strategy.
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Table 3 CMR results
CMR Results
Positive Stress CMR
85% maximal HR reached 10
85% maximal HR not reached 4
Negative Stress CMR
85% maximal HR reached 153
85% maximal HR not reached 1
Figure 1
Table 2 Hemodynamic response
Rest Stress
Heart Rate (BPM) 71.2 ± 12.1 130.1 ± 12.6
Systolic Blood Pressure (mmHg) 142.8 ± 19.3 154.8 ± 85.3
Diastolic Blood Pressure (mmHg) 80.6 ± 12.3 85.3 ± 15.1
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